4//SEC Filing
Cabell Christopher 4
Accession 0001193125-26-006350
CIK 0001750149other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:21 PM ET
Size
5.3 KB
Accession
0001193125-26-006350
Insider Transaction Report
Form 4
Cabell Christopher
President & Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2026-01-05+900,117→ 900,117 totalExercise: $2.01Exp: 2036-01-05→ Common Stock (900,117 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest and become exercisable in 36 equal monthly installments commencing from January 5, 2026, subject to the Reporting Person's continued employment through each such vesting date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001814928
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:21 PM ET
- Size
- 5.3 KB